WIN 2020 Program

Please see below for details of both Sunday and Monday's program:

 

Integrating Genomics and Transcriptomics to reshape Precision Oncology: A WINning Strategy

 

MONDAY 22nd JUNE, 2020

SESSION 3: DISRUPTIVE CONCEPTS AND METHODOLOGICAL INNOVATIONS IN PRECISION ONCOLOGY

 

Keynote Lecture
Computational tools for patients stratification

Shawn Murphy

Harvard Partners, Boston, USA

 

Keynote Lecture
Consensus molecular subtypes in colon cancer and implications for therapy selection

Sabine Tejpar

University of Leuven, Belgium

 

Predictive biomarkers for immune checkpoint inhibitor treatment

Jean-Charles Soria

Gustave Roussy, Villejuif, France

SESSION 4: PREDICTIVE BIOMARKERS TO GUIDE THERAPY SELECTION

 

Keynote Lecture
TAPUR and derived trials (DRUP, CAPTUR, MOST)

Richard L. Schilsky

American Society of Clinical Oncology (ASCO), Alexandria, USA

 

IO in combination: The SPRING trial tri-therapy approach

Benjamin Solomon

WIN Consortium, Villejuif, France
Avera Cancer Institute, Sioux Falls, USA

 

Biomarker challenges and PanOncology Study concept

Stefan Scherer

GlaxoSmithKline (GSK), Philadelphia, USA

 

Phase 3 trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma: comprehensive tumor genomic and transcriptomic analyses

Jean-François Martini

Pfizer Inc., La Jolla, USA

 

I-PREDICT: first study of personalized combination therapy

Razelle Kurzrock

University of California San Diego, USA

SESSION 5: NEW CONCEPTS AND THERAPEUTIC APPROACHES IN PRECISION ONCOLOGY ACROSS THE GLOBE: WIN MEMBERS

 

Keynote Lecture
Early stage lung cancer: challenge and opportunity

Haiquan Chen

Fudan University Shanghai Cancer Center (FUSCC), China

 

Integration of T-cell therapy in Precision Oncology clinical trials

Apostolia M. Tsimberidou

The University of Texas MD Anderson Cancer Center, Houston, USA

 

Challenges and prospects of precision medicine in the community oncology setting

Rodrigo Dienstmann

Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

 

Use of transcriptomics (RNASeq) in the clinic

Tobias Meissner

Avera Cancer Institute, Sioux Falls, USA

 

Expanding Precision Oncology across tumor types: advances in prostate cancer

Joaquín Mateo

Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

SESSION 6: BEST POSTERS' AWARD

 

Best 2 Posters Presentations and Awards

 

Conclusions

Richard L. Schilsky 

Chairman WIN Consortium, Villejuif, France
American Society of Clinical Oncology (ASCO), Alexandria, USA

Josep Tabernero

Vice-Chairman WIN Consortium, Villejuif, France
Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

WIN 2021 Symposium
c/o MCI UK Ltd
Durford Mill
Petersfield
GU31 5AZ

Tel: +44 (0) 1730 715223
General enquiries: winsymposium@mci-group.com
Sponsorship enquiries: winsymposium@mci-group.com
Abstract enquiries: winsympabstracts@mci-group.com
Registration enquiries: winsympreghot@mci-group.com

View Our Privacy Policy Here